[{"address1": "1075 West Georgia Street", "address2": "Suite 1890", "city": "Vancouver", "state": "BC", "zip": "V6E 3C9", "country": "Canada", "phone": "604 687 2038", "website": "https://mydecine.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. It also develops MYCO-005, MYCO-006, and MYCO-007 for MDMA and psilocybin analogs. The company has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. Mydecine Innovations Group Inc. was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David Joshua Bartch", "age": 37, "title": "Co-Founder, CEO, President & Chairman of the Board", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 338248, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Roscow M.A.", "title": "Co-Founder", "fiscalYear": 2024, "totalPay": 346462, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Damon  Michaels", "title": "Co-Founder", "fiscalYear": 2024, "totalPay": 346462, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Charles Ross CA, CPA, M.B.A.", "age": 66, "title": "CFO & Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 44278, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rakesh  Jetly FRCPC, M.D.", "title": "Chief Medical Officer", "fiscalYear": 2024, "totalPay": 277553, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. William  Cook", "title": "Interim CEO & Technical Director of Mindleap Health Inc.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.096, "open": 0.0037, "dayLow": 0.0037, "dayHigh": 0.0037, "regularMarketPreviousClose": 0.096, "regularMarketOpen": 0.0037, "regularMarketDayLow": 0.0037, "regularMarketDayHigh": 0.0037, "payoutRatio": 0.0, "trailingPE": "Infinity", "forwardPE": 0.0384, "volume": 140, "regularMarketVolume": 140, "averageVolume": 290, "averageVolume10days": 0, "averageDailyVolume10Day": 0, "bid": 0.0027, "ask": 0.0069, "bidSize": 49860, "askSize": 20000, "marketCap": 255306, "fiftyTwoWeekLow": 0.0037, "fiftyTwoWeekHigh": 0.45, "allTimeHigh": 5500.0, "allTimeLow": 0.029, "fiftyDayAverage": 0.20642, "twoHundredDayAverage": 0.222605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 7013767, "profitMargins": 0.0, "floatShares": 1205589, "sharesOutstanding": 1235107, "heldPercentInsiders": 0.0239, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 2659446, "bookValue": -12.274, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": 2285519, "trailingEps": 0.0, "forwardEps": 2.5, "lastSplitFactor": "1:50", "lastSplitDate": 1761004800, "52WeekChange": -0.616, "SandP52WeekChange": 0.09209216, "quoteType": "EQUITY", "currentPrice": 0.096, "recommendationKey": "none", "totalCash": 47081, "totalCashPerShare": 0.038, "totalDebt": 6942772, "quickRatio": 0.003, "currentRatio": 0.003, "returnOnAssets": 8.47172, "freeCashflow": -2094236, "operatingCashflow": -10092, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MYCOF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChange": 0.0, "regularMarketDayRange": "0.0037 - 0.0037", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 290, "fiftyTwoWeekLowChange": 0.0923, "fiftyTwoWeekLowChangePercent": 24.945946, "fiftyTwoWeekRange": "0.0037 - 0.45", "fiftyTwoWeekHighChange": -0.35399997, "fiftyTwoWeekHighChangePercent": -0.78666663, "fiftyTwoWeekChangePercent": -61.6, "dividendDate": 1554076800, "corporateActions": [], "regularMarketTime": 1763758800, "exchange": "PNK", "messageBoardId": "finmb_286101205", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "MYDECINE INNOVATIONS GROUP INC ", "longName": "Mydecine Innovations Group Inc.", "regularMarketChangePercent": 0.0, "regularMarketPrice": 0.096, "marketState": "CLOSED", "earningsTimestampStart": 1751286600, "earningsTimestampEnd": 1751632200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.0, "epsForward": 2.5, "fiftyDayAverageChange": -0.11042, "fiftyDayAverageChangePercent": -0.5349288, "twoHundredDayAverageChange": -0.126605, "twoHundredDayAverageChangePercent": -0.5687429, "priceToBook": -0.007821411, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "displayName": "Mydecine Innovations", "trailingPegRatio": null, "__fetch_time": "2025-11-22"}]